Revvity Inc.
USUSDRevvity Inc. (LSE:0KHE) — Biotechnology: Laboratory Analytical Instruments. Number of exchanges where the company shares trade: 3. On this page — price and chart, dividends, top holders and share count history.
About the company
- Website
- revvity.com
- Investor relations
- ir.revvity.com/home/default.aspx
- Sector
- Industrials · Biotechnology: Laboratory Analytical Instruments
- Headquarters
- Waltham, United States
- CEO
- Prahlad R. Singh
- Employees
- 11 000
- Shares outstanding
- 111.59 M as of 2026-08-06
- Free float
- 102.49 M
- Market cap
- 16.63 B USD
- Insiders
- 0.26%
- Institutions
- 96.55%
- Industry (SIC)
- Laboratory Analytical Instruments
- Legal form
- ZJTK
- LEI
- 549300IKL1SDPFI7N655
- Payout ratio
- 13.4%
- FCF
- 558 M USD
- Payout / FCF
- 6%
- Debt
- 3.21 B USD3.9 y of FCF
- Dividend streak
- 43 y
- Earnings, FCF and dividends paid — for the 12 months to 05.07.2026 (the company's latest report).
- NAV
Description
Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents, assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. The company also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, chemagic, Chitas, CNGnome, DELFIA, DELFIA Xpress, EONIS, EUROArray , EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, GSP, Haoyuan, IDS Immunodiagnosticsystems, IDS-i10, IDS-i10T, IDS-i20, IDS-iSYS, iLab, iQ, LifeCycle, LimsLink, Migele, NeoBase, NeoLSD, NEXTFLEX, Panthera Puncher, PreNAT II, Prime, RONIA, SimplicityChrom, Specimen Gate, Superflex, Symbio, T-SPOT, Vanadis, ViaCord, VICTOR2, and WholePanel brand names, as well as under the Accell, AlphaLISA, AlphaPlex, AlphaScreen, Alpha SureFire, AssayMate, BIOCHIPs, BioLegend, Bioo Scientific, BioQule, Brilliant Violet, Ce3D, CellCarrier, Cellaca, Celigo, Cellometer, cell::explorer, Cell-Vive, Chalice, ChemDraw, CHOSOURCE, Dharmacon, and DharmaFECT brand names. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
Dividends
Revvity Inc. (RVTY) pays dividends quarterly. Per year (12 months up to and including the latest announced payment): 0.28 USD per share (payments: 4). That is about 0.19% of the current share price. The next ex-dividend date is 23.10.2026: 0.07 USD per share, paid on 13.11.2026. Uninterrupted dividend history: 43 years.
| Ex-date | Payment | Amount | % | Type | Ticker |
|---|---|---|---|---|---|
| 2026-10-23 announced | 2026-11-13 | 0.0700 USD | 0.0/0.2 % | quarterly | US:RVTY |
| 2026-07-17 | 2026-08-07 | 0.0700 USD | 0.1/0.3 % | quarterly | US:RVTY |
| 2026-04-17 | 2026-05-08 | 0.0700 USD | 0.1/0.3 % | quarterly | US:RVTY |
| 2026-01-16 | 2026-02-06 | 0.0700 USD | 0.1/0.2 % | quarterly | US:RVTY |
| 2025-10-17 | 2025-11-07 | 0.0700 USD | 0.1/0.3 % | quarterly | US:RVTY |
| 2025-07-18 | 2025-08-08 | 0.0700 USD | 0.1/0.3 % | quarterly | US:RVTY |
| 2025-04-17 | 2025-05-09 | 0.0700 USD | 0.1/0.3 % | quarterly | US:RVTY |
| 2025-01-17 | 2025-02-07 | 0.0700 USD | 0.1/0.2 % | quarterly | US:RVTY |
| 2024-10-18 | 2024-11-08 | 0.0700 USD | 0.1/0.2 % | quarterly | US:RVTY |
| 2024-07-19 | 2024-08-09 | 0.0700 USD | 0.0/0.2 % | quarterly | US:RVTY |
| 2024-04-18 | 2024-05-10 | 0.0700 USD | 0.0/≈0.2 % | quarterly | US:RVTY |
| 2024-01-18 | 2024-02-09 | 0.0700 USD | 0.0/≈0.2 % | quarterly | US:RVTY |
| 2023-10-19 | 2023-11-10 | 0.0700 USD | 0.0/≈0.2 % | quarterly | US:RVTY |
Top holders
| Holder | Stake | Shares | Report date |
|---|---|---|---|
| T. Rowe Price Investment… | 16.37% | 18.26 M | 2026-06-30 |
| T. ROWE PRICE CAPITAL AP… | 10.2% | 11.38 M | 2026-06-30 |
| Jupiter Topco LLC | 7.74% | 8.64 M | 2026-06-30 |
| Edgepoint Investment Gro… | 7.66% | 8.54 M | 2026-06-30 |
| Blackrock Inc. | 6.86% | 7.66 M | 2026-06-30 |
| Vanguard Capital Managem… | 6.54% | 7.3 M | 2026-06-30 |
| JANUS INVESTMENT FUND-Ja… | 5.15% | 5.75 M | 2026-06-30 |
| Price (T.Rowe) Associate… | 4.96% | 5.53 M | 2026-06-30 |
| Vanguard Portfolio Manag… | 4.28% | 4.77 M | 2026-06-30 |
| State Street Corporation | 3.89% | 4.34 M | 2026-06-30 |
| Victory Capital Manageme… | 3.27% | 3.65 M | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 3.18% | 3.55 M | 2026-06-30 |
| Dimensional Fund Advisor… | 3.07% | 3.43 M | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.59% | 2.89 M | 2026-06-30 |
| -Price (T.Rowe) U.S. Val… | 2.41% | 2.69 M | 2026-06-30 |
| TR PRICE-Price (T.Rowe)… | 2.41% | 2.69 M | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.29% | 2.56 M | 2026-06-30 |
| JNL Series Trust-JNL/T.… | 2.27% | 2.53 M | 2026-06-30 |
| Victory Portfolios-Victo… | 2.12% | 2.37 M | 2026-06-30 |
| T. Rowe Price Value Fund… | 1.93% | 2.16 M | 2026-06-30 |
| Invesco Exchange-Traded… | 1.67% | 1.87 M | 2026-08-31 |
| SINGH PRAHLAD R (Chief E… | ≈0.09% | 105 676 | 2026-08-13 |
| GOLDBERG JOEL S (General… | ≈0.09% | 105 223 | 2026-08-14 |
| BARRETT PETER (Director) | ≈0.03% | 28 293 | 2026-05-07 |
| WITNEY FRANKLIN R. PH.D.… | ≈0.02% | 23 354 | 2026-05-07 |
| CHAPIN SAMUEL R. (Direct… | ≈0.02% | 22 676 | 2026-05-07 |
| VICTOR MIRIAME (Officer) | ≈0.02% | 18 122 | 2026-02-24 |
| WITZ PASCALE (Director) | ≈0.01% | 15 985 | 2026-05-07 |
| KRAKOWIAK MAXWELL (Chief… | ≈0.01% | 14 781 | 2026-09-21 |
| MICHAS ALEXANDROS P (Dir… | — | — | 2026-08-25 |
| MICHAS ALEXIS P (Directo… | — | — | 2025-08-27 |
